Healthcare provider profile · identity verified

Dale J Meyer, MD

Internal Medicine · WOODBURY, MN · NPI 1023089430

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	837	234
Amlodipine Besylate	Amlodipine Besylate	427	117
Lisinopril	Lisinopril	348	103
Omeprazole	Omeprazole	348	102
Hydrochlorothiazide	Hydrochlorothiazide	316	89
Losartan Potassium	Losartan Potassium	288	76
Metoprolol Succinate	Metoprolol Succinate	273	80
Levothyroxine Sodium	Levothyroxine Sodium	241	65
Simvastatin	Simvastatin	228	62
Rosuvastatin Calcium	Rosuvastatin Calcium	197	62
Tamsulosin Hcl	Tamsulosin Hcl	195	58
Metformin Hcl Er	Metformin Hcl	178	51
Eliquis	Apixaban	173	37
Gabapentin	Gabapentin	160	50
Metformin Hcl	Metformin Hcl	148	48
Ozempic	Semaglutide	122	22
Warfarin Sodium	Warfarin Sodium	121	25
Allopurinol	Allopurinol	113	32
Glipizide Er	Glipizide	111	30
Atenolol	Atenolol	110	29
Sertraline Hcl	Sertraline Hcl	106	33
Furosemide	Furosemide	101	39
Xarelto	Rivaroxaban	98	20
Fluticasone Propionate	Fluticasone Propionate	89	38
Finasteride	Finasteride	88	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	26
Metoprolol Tartrate	Metoprolol Tartrate	85	32
Fluoxetine Hcl	Fluoxetine Hcl	81	20
Potassium Chloride	Potassium Chloride	78	25
Jardiance	Empagliflozin	76	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	22
Lorazepam	Lorazepam	73	16
Spironolactone	Spironolactone	70	21
Ezetimibe	Ezetimibe	64	15
Citalopram Hbr	Citalopram Hydrobromide	57	17
Albuterol Sulfate Hfa	Albuterol Sulfate	56	21
Carvedilol	Carvedilol	56	17
Famotidine	Famotidine	56	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	13
Pantoprazole Sodium	Pantoprazole Sodium	53	14
Trazodone Hcl	Trazodone Hcl	51	17
Clopidogrel	Clopidogrel Bisulfate	50	15
Escitalopram Oxalate	Escitalopram Oxalate	49	13
Amitriptyline Hcl	Amitriptyline Hcl	48	suppressed
Bupropion Hcl Sr	Bupropion Hcl	47	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	13
Chlorthalidone	Chlorthalidone	41	13
Lansoprazole	Lansoprazole	40	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Glipizide	Glipizide	36	13
Prednisone	Prednisone	36	18
Tramadol Hcl	Tramadol Hcl	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Acyclovir	Acyclovir	31	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	14
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Bumetanide	Bumetanide	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Azithromycin	Azithromycin	22	17
Baclofen	Baclofen	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	16
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Propranolol Hcl	Propranolol Hcl	18	suppressed
Colchicine	Colchicine	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	17
Synthroid	Levothyroxine Sodium	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Gemfibrozil	Gemfibrozil	14	suppressed
Nystatin	Nystatin	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Admelog Solostar	Insulin Lispro	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ramipril	Ramipril	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error